Why healthcare startups fail and 5 that bit the dust in 2018
Healthcare VCs provided their thoughts on why startups die, followed by a roundup of five companies that didn't survive 2018.
Is Driver a story of fast fail or a cautionary tale against pursuing DTC model?
Driver reportedly raised around $100 million and had top medical minds on its scientific advisory board, but the $3,000 price tag for its services that its cancer patients would have to pay appears to have been a flawed model to begin with.
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Report: Cancer clinical trials tech startup Driver shutters two months after launch
The high cost to join the platform - which combined molecular pathology labs with a mobile app - played a role in its low sign-up numbers, CEO says.